share_log

424B5: Prospectus

424B5: Prospectus

424B5：募資說明書
美股SEC公告 ·  08/02 16:39

Moomoo AI 已提取核心訊息

60 Degrees Pharmaceuticals, Inc. has announced an increase in the maximum aggregate gross sales price of shares available under its At the Market Issuance Sales Agreement with WallachBeth Capital LLC to $2,295,192. This update, filed on August 2, 2024, amends previous prospectus supplements and the base prospectus, reflecting the increased offering size from the initial registration of $1,253,603. As of the filing date, the company has sold 8,133,821 shares for a total of $1,994,583.43. The common stock is traded on The Nasdaq Capital Market under the symbol 'SXTP.' The company's outstanding common stock held by non-affiliates is valued at approximately $6,885,578, based on the closing sale price on June 10, 2024. 60 Degrees Pharmaceuticals emphasizes that investing in its common stock carries significant risks, as detailed in the 'Risk Factors' section of the prospectus supplements and documents filed with the SEC.
60 Degrees Pharmaceuticals, Inc. has announced an increase in the maximum aggregate gross sales price of shares available under its At the Market Issuance Sales Agreement with WallachBeth Capital LLC to $2,295,192. This update, filed on August 2, 2024, amends previous prospectus supplements and the base prospectus, reflecting the increased offering size from the initial registration of $1,253,603. As of the filing date, the company has sold 8,133,821 shares for a total of $1,994,583.43. The common stock is traded on The Nasdaq Capital Market under the symbol 'SXTP.' The company's outstanding common stock held by non-affiliates is valued at approximately $6,885,578, based on the closing sale price on June 10, 2024. 60 Degrees Pharmaceuticals emphasizes that investing in its common stock carries significant risks, as detailed in the 'Risk Factors' section of the prospectus supplements and documents filed with the SEC.
60 Degrees Pharmaceuticals, Inc.宣佈將其與WallachBeth Capital LLC的市場發行銷售協議下的股票的最大總銷售價格上調至$2,295,192。此更新於2024年8月2日提交，修改了之前的招股說明書補充和基礎招股說明書，反映了從最初註冊的$1,253,603增加的發售規模。截至提交日期，該公司已出售8,133,821股股票，總價值爲$1,994,583.43。普通股票在納斯達克資本市場以符號'SXTP'交易。公司未與關聯方持有的普通股價值約爲$6,885,578，根據2024年6月10日的收盤價計算。60 Degrees Pharmaceuticals強調，投資其普通股具有重大風險，詳見招股說明書補充和提交給SEC的文件中的“風險因素”部分。
60 Degrees Pharmaceuticals, Inc.宣佈將其與WallachBeth Capital LLC的市場發行銷售協議下的股票的最大總銷售價格上調至$2,295,192。此更新於2024年8月2日提交，修改了之前的招股說明書補充和基礎招股說明書，反映了從最初註冊的$1,253,603增加的發售規模。截至提交日期，該公司已出售8,133,821股股票，總價值爲$1,994,583.43。普通股票在納斯達克資本市場以符號'SXTP'交易。公司未與關聯方持有的普通股價值約爲$6,885,578，根據2024年6月10日的收盤價計算。60 Degrees Pharmaceuticals強調，投資其普通股具有重大風險，詳見招股說明書補充和提交給SEC的文件中的“風險因素”部分。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間